Skip to main content

Henry Schein Value Stock - Dividend - Research Selection

Henry schein

ISIN: US8064071025 , WKN: 897961

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

We believe we are the world’s largest provider of health care products and services primarily to office-based dental, animal health and medical practitioners.  We serve more than 1 million customers worldwide including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics.  We believe that we have a strong brand identity due to our more than 84 years of experience distributing health care products.   We are headquartered in Melville, New York, employ more than 21,000 people (of which more than 10,500 are based outside the United States) and have operations or affiliates in 33 countries, including the United States, Australia, Austria, Belgium, Brazil, Canada, Chile, China, the Czech Republic, Denmark, France, Germany, Hong Kong SAR, Iceland, Ireland, Israel, Italy, Japan, Luxembourg, Malaysia, the Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Slovakia, South Africa, Spain, Sweden, Switzerland, Thailand and the United Kingdom.   We offer a comprehensive selection of products and services and value-added solutions for operating efficient practices and delivering high quality care.  We operate through a centralized and automated distribution network with a selection of more than 120,000 branded products and Henry Schein private brand products in stock, as well as more than 180,000 additional products available as special order items.  We also offer our customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.   We have established over 4.5 million square feet of space in 62 strategically located distribution centers around the world to enable us to better serve our customers and increase our operating efficiency.  This infrastructure, together with broad product and service offerings at competitive prices, and a strong commitment to customer service, enables us to be a single source of supply for our customers’ needs.  Our infrastructure also allows us to provide convenient ordering and rapid, accurate and complete order fulfillment.   We conduct our business through two reportable segments: (i) health care distribution and (ii) technology and value-added services.  These segments offer different products and services to the same customer base.    The health care distribution reportable segment aggregates our global dental, animal health and medical operating segments.  This segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.  Our global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions.  Our global animal health group serves animal health practices and clinics.  Our global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions.    Our technology and value-added services group provides software, technology and other value-added services to health care practitioners.  Our technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics.  Our value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners. Source:
The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


BD's (BDX) New FDA Approval to Improve Vaginitis Testing

BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of vaginitis.

Henry Schein Inc. stock rises Thursday, still underperforms market

Shares of Henry Schein Inc. inched 0.85% higher to $78.15 Thursday, on what proved to be an all-around great trading session for the stock market, with the...

Catalent's (CTLT) Tie-Up to Accelerate Clinical Trial Timelines

Catalent's (CTLT) latest collaboration is expected to leverage multiple services that reduce drug development timelines.

Shockwave Medical (SWAV) Launches New IVL Catheter in U.S.

Shockwave Medical's (SWAV) latest U.S. launch is expected to serve a wider patient pool.

Henry Schein Inc. stock outperforms market despite losses on the day

Shares of Henry Schein Inc. sank 0.36% to $77.49 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

The Zacks Analyst Blog Highlights Ameriprise Financial, Everest Re Group, Microchip Technology, Henry Schein and HSBC Holdings

Ameriprise Financial, Everest Re Group, Microchip Technology, Henry Schein and HSBC Holdings are part of the Zacks top Analyst Blog.

Henry Schein Inc. stock rises Tuesday, still underperforms market

Shares of Henry Schein Inc. inched 0.27% higher to $77.77 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...

Henry Schein (HSIC) Aids Growth of Ambulatory Surgery Centers

Henry Schein (HSIC) joined ASCA as part of its commitment to augment the value of ambulatory surgery centers.

OPKO Health (OPK) to Develop EBV Vaccine With Latest Tie-Up

OPKO Health's (OPK) entry into a worldwide license and collaboration agreement with Merck is expected to aid in developing a vaccine against EBV.